Moreover, the upregulation of TP73-AS1 was associated with a poorer DFS in adrenocortical carcinoma (ACC), low grade glioma (LGG), colon adenocarcinoma (COAD), prostate adenocarcinoma (PRAD) and stomach adenocarcinoma (STAD) (log-rank P < 0.05) (Fig. 6c-g). Here, TP73 is linked to adrenal cortex carcinoma.